Prebiotics, probiotics and symbiotics and their relationship with colorretal cancer
Keywords:Colorectal Neoplasms; Intestinal microbiota; Immunomodulatory Therapies; Nutrition.
Objective: To identify based on the scientific literature the effects on the use of probiotics and symbiotics in the treatment of colorectal cancer (RCC). Method: This is an integrative review study, conducted in February 2019, with the theme focused on the use of probiotics and symbiotics in RCC. To guide the study the following question was asked: “What is the influence of the use of probiotics or symbiotics in individuals with colorectal cancer?” To survey the articles in the literature, we searched the following databases: LILACS, Medline, Scielo and Pubmed. The following keywords were used to search for the articles: 'Colorectal Neoplasms', 'Probiotics', 'Synbiotics' and 'Nutrition', both used alone or in combinations in Portuguese and English. Results: RCC is the third most common type in the world and has a multifactorial etiology involving heredity, chronic inflammatory diseases, age, diet, obesity, physical inactivity and other factors. The treatment is still associated with a high risk of complications and the use of immunomodulatory diets with the use of probiotics or symbiotics represents a new therapeutic option and its function is to act in prevention and to be allied to the treatment of RCC, becoming of great importance. for the quantitative and qualitative balance of the intestinal microbiota for human health and their importance as adjuvants in the prevention and treatment of colorectal cancer. Conclusion: Probiotic or symbiotic administration is effective for intestinal health, preserving and stimulating beneficial bacteria, promoting intestinal health and decreasing inflammatory activity and the risk of infections after surgical resections.
ACS. (2018). American Cancer Society and Cancer Facts and Figures. Atlanta: American Cancer Society.
Aachary, A. A. & Prapulla, S. G. (2011). Xylooligosaccharides (XOS) as an emerging prebiotic: microbial synthesis, utilization, structural characterization, bioactive properties, and applications. Comp Rev Food Sci Food Saf., 1(10), 2-16.
Ambalam, P., Raman, M., Purama, RK. & Doble, M. (2016). Probiotics, prebiotics and colorectal câncer prevention. Best Pract Res Clin Gastroenterol, 1(30), 119-131.
Birt, D. F., Boylston, T., Hendrich, S., Jane, J. L., Hollis, J., Li, L., et al. (2013). Resistant starch: promise for improving human health. Adv Nutr., 4(1), 587-601.
Bishehsari, F., Mahdavinia, M., Vacca, M., Malekzadeh, R., & Mariani-Costantini, R. (2014). Epidemiological transition of colorectal cancer in developing countries: environmental factors, molecularpathways, and opportunities for prevention. World J Gastroenterol., 1(20), 6055-6072.
Denipote, F. G., Trindade, E. B. S. M., & Burini, R. C. (2010). Probióticos e Prebióticos na atenção primária ao câncer de cólon. Arq Gastroenterol., 47(1), 93-98.
Elmunzer, B. J., Hayward, R. A., Schoenfeld, P. S., Saini, S. D., Deshpande, A., & Waljee, A. K. (2012). Effect of flexible sigmoidoscopy- based screening on incidence and mortality of colorectal câncer: a systematic review and meta-analysis of randomized controlled trials. Plos Medicine, 9(1), 1001-1013.
Flesch, A. T., Tonial, S. T., Contu, P. C., & Damin, D. C. (2017). Perioperative synbiotics administration decreases postoperative infections in patients with colorectal cancer: a randomized, double-blind clinical trial. Rev. Col. Bras. Cir., 44(6), 567-573.
Guarner, F., Sanders, M. E., Eliakim, R., Fedorak, R., Gangl, A., Garisch, J., et al. (2017). Diretrizes Mundiais da Organização Mundial de Gastroenterologia: Probióticos e prebióticos. World Gastroenterology Organisation, 1-35.
Hirayama, K., & Rafter, J. (2012). The role of probiotic bacteria in cancer prevention. Microbes Infect., 2(1), 681-686.
INCA. Instituto Nacional de Câncer José Alencar Gomes da Silva. Coordenação de Prevenção e Vigilância. Estimativa 2018: Incidência de Câncer no Brasil. Instituto Nacional de Câncer José Alencar Gomes da Silva, Coordenação de Prevenção e Vigilância. Rio de Janeiro.
Kahouli, I., Malhotra, M., Westfall, S., Alaoui-Jamali, M. A. & Prakash, S. (2017). Design and validation of an orally administrated active L. fermentum-L. acidophilus probiotic formulation using colorectal cancer Apc Min/+ mouse model. Appl Microbiol Biotechnol., 105(5), 1999- 2019.
Kuugbee, E. D., Eugene, S. X., Gamallat, Y., Bamba, D., Awadasseid, A., Suliman, M. A., et al. (2016). Structural Change in Microbiota by a Probiotic Cocktail Enhances the Gut Barrier and Reduces Cancer via TLR2 Signaling in a Rat Model of Colon Cancer. Dig Dis Sci., 61(1), 2908-2920.
Machado, F. F., Lazzaretti, R. K. & Poziomyck, A. K. (2014). Use of Prebiotics, Probiotics and Symbiotics in Pre and Postoperative of Colorectal Cancer: A Review. Revista Brasileira de Cancerologia, 60(4), 363-370.
Ohigashi, S., Hoshino, Y., Ohde, S., & Onodera, H. (2011). Functional outcome quality of life and efficacy of probiotics in postoperative patients with colorectal cancer. Surgery Today, 41(1), 1200–1206.
Oliveira, A. L. (2013). O papel dos simbióticos na prevenção, tratamento e modulação da resposta inflamatória em pacientes com carcinoma colorretal. Revista Interdisciplinar de Estudos Experimentais, 1(4), 23-31.
Oliveira, A. L., & Aarestrup, F. M. (2012). Avaliação nutricional e atividade inflamatória sistêmica de pacientes com câncer colorretal submetidos à suplementação com simbiótico. ABCD Arq Bras Cir Dig., 25(3), 147-153.
Pereira, A. S., Shitsuka, D. M., Parreira, F. J., & Shitsuka, R. (2018). Metodologia da pesquisa científica. Ed. UAB/NTE/UFSM, Santa Maria/RS. Disponível em: https://repositorio.ufsm.br/bitstream/handle/1/15824/Lic_Computacao_Metodologia-Pesquisa-Cientifica.pdf?sequence=1. Acesso em: 29 julho 2019.
Pitino, I., Randazzo, C. L., Cross, K. L., Parker, M. L., Bisignano, C., & Wickham, M. S. (2012). Survival of Lactobacillus rhamnosus strains inoculated in cheese matrix during simulated human digestion. Food Microbiol., 31(1), 57-63.
Rowland, I. R., Rumney, C. J., Coutts, J. T., & Lievense, L. C. (2013). Effect of Bifidobacterium longum and inulin on gut bacterial metabolism and carcinogen-induced aberrante crypt foci in rats. Carcinogenesis, 19(1), 281-285.
Stigliano, V., Sanchez-Mete, L., Martayan, A., & Anti, M. (2014). Early-onset colorectal cancer: A sporadic or inherited disease?. World J Gastroenterol., 20(35), 12420-12430.
Salehipour, Z., Haghmorad, D., Sankian, M., Rastin, M., Nosratabadi, R., Dallal M. M., et al. (2017). Bifidobacterium animalis in combination with human origin of Lactobacillus plantarum ameliorate neuroinflammation in experimental model of multiple sclerosis by altering CD4+ T cell subset balance. Biomed Pharmacother, 95(1), 1535-1548.
Zene, K. L., Michalichen, K. C., Molinari, L., Taques, N., Lacerda, P. S., & Cavagnari, M. A. V. (2018). Ação de prebióticos e próbioticos em indivíduos com câncer colorretal: revisão integrativa. Revista Uningá Review, 29(3).
How to Cite
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.